The Society for Cardiovascular Angiography & Interventions (SCAI) has published an expert consensus statement that provides ...

Executives expect a new label indication and a hoped-for easing of hospital capacity constraints to accelerate sales this year.

The agency announced on November 2, 2011 that it had approved Edwards Lifesciences' first-generation Sapien TAVR device for patients with severe aortic stenosis who are ineligible for open-heart ...

The Society for Cardiovascular Angiography & Interventions (SCAI) has published an expert consensus statement that provides interventional cardiologists, cardiothoracic surgeons, and heart teams with ...

Medtronic also recently teamed with Tempus to assess the use of artificial intelligence to identify people eligible for ...

In particular, research on Edwards' market-leading Sapien TAVR device suggests that the learning curve is 200 cases. That's the inflection point where the physician can deliver optimal patient ...

The UHS Heart & Vascular Institute recently celebrated a significant milestone with the completion of their 1,000th TAVR (Transcatheter Aortic Valve Replacement) procedure. This achievement is ...

The company's lead product, transcatheter aortic valve replacement (TAVR) device, is used for minimally invasive heart surgeries. Sales from the TAVR unit rose nearly 6% to $1.04 billion in the ...

Minimally invasive heart procedures like transcatheter aortic valve replacement (TAVR) and MitraClip placement to treat mitral regurgitation can improve quality of life, and even be lifesaving, for ...

The firm recently retrenched in the transcatheter aortic valve market after discontinuing its Lotus device. Though we're not particularly optimistic about its new Acurate Neo TAVR franchise ...

TMTT sales surged 77% in 2023 to $352M, driven by PASCAL and EVOQUE adoption. TAVR sales reached $1.04B in Q4, up 5.3% year-over-year. Get 5 stock picks identified before their biggest breakouts ...

Edwards Lifesciences beat analysts' estimate for fourth-quarter profit on Tuesday, helped by strong demand for its artificial heart valves and other medical devices. Investors remain bullish on ...